Vanícek J, Adam Z, Balsíková K, Krejcí M, Pour L, Szturz P, Zahradová L, Hájek R, Koukalová R, Rehák Z, Král Z, Mayer J
Klinika zobrazovacích metod Lékarské fakulty MU a FN u sv. Anny v Brne.
Vnitr Lek. 2011 Oct;57(10):871-5.
In adult patients, Langerhans cell histiocytosis (LCH) manifests most frequently with one or more osteolytic lesions or, alternatively, with pulmonary involvement with nodules and cysts or with skin lesions. Infiltration ofthe central nervous system is a rather rare sign of LCH. The LCH cells have an unexplained affinity to hypothalamus and to pituitary stalk and, consequently, central diabetes insipidus is the most frequent clinical sign of brain involvement in LCH. We describe treatment of 2 adult patients with LCH in whom central diabetes insipidus was the first sign of LCH and MR confirmed pituitary stalk infiltration. The first man was diagnosed with diabetes insipidus and pituitary stalk infiltration at 33 years of age. LCH was confirmed 2 years later by histology of verrucous lesions on the skin of perianal area. The disease affected the skin and CNS. The patient was treated with 2-chlorodeoxyadenosine (5 mg/m2 s.c. for 5 consecutive days of a 28-day cycle). No pituitary infiltration was evident on an MR image after the 4th cycle. Residual perianal infiltration was irradiated. The patient has been in complete remission for 44 months following treatment completion, although vasopressin and testosterone substitution is required. The second man was also diagnosed with diabetes insipidus and pituitary stalk infiltration at 33 years of age. Pulmonary involvement was identified with high resolution CT(HRCT) and high CD1a and S-100 positive elements with bronchoalveolar lavage. This patient further had external auditory canal infiltrations causing chronic discharge from the ears. The patient was treated with 2-chlorodeoxyadenosine as above. A follow up MR after the 4th cycle showed reduction in the infiltration diameter from 5.5 to 3.0 mm. Therefore, 2-chlorodeoxyadenosine 5 mg/m2 s.c. was combined with dexamethasone 20 mg p.o. during the 5th and 6th cycle. The MR image after treatment completion showed remission of the pituitary stalk infiltrate. External auditory canal infiltration diminished as did the nodules in pulmonary parenchyma. Nevertheless, vasopressin substitution is still required. The patient has been in complete remission for 8 months from the completion of the treatment. Pituitary stalk infiltration disappeared after the treatment with 2-chlorodeoxyadenosine in 2 patients; after 4 cycles in the first and after 6 cycles (with an addition of dexamethasone during the last 2 cycles) in the second.
在成年患者中,朗格汉斯细胞组织细胞增多症(LCH)最常表现为一个或多个溶骨性病变,或者表现为肺部受累,出现结节和囊肿,或表现为皮肤病变。中枢神经系统受累是LCH相当罕见的体征。LCH细胞对下丘脑和垂体柄有一种无法解释的亲和力,因此,中枢性尿崩症是LCH脑部受累最常见的临床体征。我们描述了2例成年LCH患者的治疗情况,这2例患者均以中枢性尿崩症作为LCH的首发体征,且磁共振成像(MR)证实存在垂体柄浸润。首例男性患者33岁时被诊断为尿崩症和垂体柄浸润。2年后,通过肛周皮肤疣状病变的组织学检查确诊为LCH。该疾病累及皮肤和中枢神经系统。患者接受2-氯脱氧腺苷治疗(28天周期中连续5天皮下注射5mg/m²)。第4个周期后,MR图像显示垂体无浸润。对残留的肛周浸润进行了放射治疗。治疗结束后,患者已完全缓解44个月,不过仍需要血管加压素和睾酮替代治疗。第二例男性患者同样在33岁时被诊断为尿崩症和垂体柄浸润。高分辨率CT(HRCT)检查发现肺部受累,支气管肺泡灌洗显示高CD1a和S-100阳性细胞成分。该患者还存在外耳道浸润,导致耳部慢性流脓。患者接受上述2-氯脱氧腺苷治疗。第4个周期后的随访MR显示浸润直径从5.5mm缩小至3.0mm。因此,在第5和第6个周期,将2-氯脱氧腺苷5mg/m²皮下注射与地塞米松20mg口服联合使用。治疗结束后的MR图像显示垂体柄浸润缓解。外耳道浸润减轻,肺实质内的结节也减少。然而,仍需要血管加压素替代治疗。该患者自治疗结束后已完全缓解8个月。2例患者经2-氯脱氧腺苷治疗后垂体柄浸润消失;首例患者在第4个周期后消失,第二例患者在第6个周期后(最后2个周期加用地塞米松)消失。